<DOC>
	<DOCNO>NCT00949234</DOCNO>
	<brief_summary>The purpose program evaluate effort provide comprehensive package HIV prevention service post-exposure prophylaxis ( medicine may help prevent HIV infection exposure ) part . It also include risk reduction information test sexually transmit infection .</brief_summary>
	<brief_title>Interventions HIV Negative Men Women Who Have High-risk Suspected Exposure HIV</brief_title>
	<detailed_description>The Los Angeles County P-QUAD program combine effort County , City , public health , community , academic , private agency individual effort provide comprehensive package HIV prevention service PEP integral component . These service design easily accessible , non-judgmental , culturally , ethnically , linguistically appropriate relevant population , community-based , independent ability pay insurance/documentation status . They also provide vital linkage associate service , routine HIV testing , primary health care . In initial pilot project , 2 community-based site serve facility patient may present screen post-exposure prophylaxis service , well sexually transmit disease . At site , initial eligibility test perform , initial 14-day supply PEP medication provide appropriate , referral initiate . All subject provide initial 14-day supply require return site remainder 28-day course medication , follow-up testing , adherence counseling , risk-reduction programming , appropriate referral . Follow-up patient phone , email , mobile-phone text message use appropriate maximize program retention .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Patients must least 18 year age Able understand provide consent HighRisk Exposure Characteristic ( one , unprotected failed condom use ) Receptive Anal Intercourse Insertive Anal Intercourse Receptive Vaginal Intercourse Insertive Vaginal Intercourse Receptive Oral Intercourse Intraoral Ejaculation know HIV+ source ( supersede `` highrisk source '' criterion ) Sharing injection drug work intravascular HighRisk Source ( one ) Known HIV positive MSM MSM/W IDU CSW Sexual perpetrator From endemic country ( prevalence &gt; 1 % ) Partner one Exposure within 72 hour presentation Not know HIV positive No countermanding concomitant medication allergy HIVnegative presentation without symptom PHI ( withhold first dose pending laboratory assessment ) . Patients &lt; 18 year age Unable understand provide consent Exposure &gt; 72 hour presentation Known HIV positive Currently inprogress course PEP initiate via nonPQUAD mechanism Any condition , opinion intake provider , seriously compromise patient 's ability comply protocol , include adherence PEP medication dose Demonstrated HIVpositive rapid test Unwillingness commit barriermethod ( male and/or female condom ) use HIVnegativestatus confirm 6 month exposure Unwillingness breastfeed woman transition formula feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>post exposure prophylaxis</keyword>
	<keyword>biomedical prevention</keyword>
	<keyword>HIV seronegativity</keyword>
</DOC>